Roche announced that it has struck an exclusive deal with Denmark's Zealand Pharma to develop and market petrelintide, a new treatment for obesity.
5d
Clinical Trials Arena on MSNNovo Nordisk’s stock drops despite CagriSema hitting goal of Phase III trialThe Wegovy successor was able to meet its primary endpoint with a 15.7% weight loss among those dosed with the combination ...
Novo Nordisk said CagriSema appeared to have a safe and well-tolerated profile in the latest trial. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate ...
Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.
The pharmaceutical industry is not stopping there. There are already 100 new drug candidates in trials, all vying for a slice ...
Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") of a class action securities lawsuit.
Novo Nordisk’s GLP-1 drug Semaglutide, sold under brand names Ozempic and Wegovy, has been hailed as a miracle drug for ...
Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Below, 112 Black-owned fashion brands to shop well beyond Black History Month. Happy shopping and supporting Black excellence! This brand brings a fun and fresh spin on classic wardrobe staples.
AbbVie on Monday jumped into the hot weight-loss space, looking to gain ground on its Big Pharma peers, with a licensing deal ...
The Rashtriya Lok Dal criticized Samajwadi Party's Akhilesh Yadav and Congress' Rahul Gandhi for their silence on Tamil Nadu CM MK Stalin's opposition to Hindi imposition. Stalin denounced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results